Skip to main content
PMC home page
Molecular Therapy logoLink to Molecular Therapy
. 2022 Aug 2;30(8):2874. doi: 10.1016/j.ymthe.2022.07.013

Preclinical and Clinical Demonstration of Immunogenicity by mRNA Vaccines against H10N8 and H7N9 Influenza Viruses

Kapil Bahl, Joe J Senn, Olga Yuzhakov, Alex Bulychev, Luis A Brito, Kimberly J Hassett, Michael E Laska, Mike Smith, Örn Almarsson, James Thompson, Amilcar (Mick) Ribeiro, Mike Watson, Tal Zaks, Giuseppe Ciaramella ∗
PMCID: PMC9372314  PMID: 35921837

Main text

(Molecular Therapy 25, 1316–1327; June 2017)

In the originally published version of this article, the sentence “LNP formulations were prepared using a modified procedure of a method previously described for siRNA” incorrectly cited reference 57. The correct reference for this sentence is reference 22.

The authors regret this error.

Articles from Molecular Therapy are provided here courtesy of The American Society of Gene & Cell Therapy

RESOURCES